Literature DB >> 9612022

[Indeterminate form of Chagas disease: considerations about diagnosis and prognosis].

A L Ribeiro1, M O Rocha.   

Abstract

The indeterminate form of Chagas' disease is defined by the absence of clinical, radiological and electrocardiographic manifestations of cardiac or digestive involvement in Trypanosoma cruzi chronic infected persons. When submitted to advanced cardiovascular tests, these patients may present significant abnormalities. However, the indeterminate form concept was reaffirmed as valid, since diagnostic criteria are simple and prognosis is benignant. In clinical practice, diagnostic difficulties are frequent, related to subjectivity and uncertain meaning of clinical, electrocardiographic and radiological findings. Moreover, indeterminate form prognosis is not equally good: after five to 10 years, a third of patients will have cardiopathy. Sudden death, a rare complication, may be the first manifestation of Chagas' disease. It is necessary to reappraise indeterminate form concept, redefining diagnostic criteria and therapeutic management. Clinical and noninvasive evaluation may allow individual risk stratification; therapeutic interventions may be beneficial in high risk groups. Since etiologic treatment may prevent cardiopathy, its role in indeterminate form management must be reassessed.

Entities:  

Mesh:

Year:  1998        PMID: 9612022     DOI: 10.1590/s0037-86821998000300008

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  19 in total

1.  Monocyte glycolysis determines CD8+ T cell functionality in human Chagas disease.

Authors:  Liliana María Sanmarco; Natalia Eberhardt; Gastón Bergero; Luz Piedad Quebrada Palacio; Pamela Martino Adami; Laura Marina Visconti; Ángel Ramón Minguez; Yolanda Hernández-Vasquez; Eugenio Antonio Carrera Silva; Laura Morelli; Miriam Postan; Maria Pilar Aoki
Journal:  JCI Insight       Date:  2019-09-19

2.  Rapidly Progressing Chagas Cardiomyopathy.

Authors:  John Hollowed; Matthew McCullough; Daniel Sanchez; Mahmoud Traina; Salvador Hernandez; Efrain Murillo
Journal:  Am J Trop Med Hyg       Date:  2016-02-08       Impact factor: 2.345

Review 3.  Chagas Cardiomyopathy in Latin America Review.

Authors:  Jefferson Luis Vieira; Fábio Rocha Fernandes Távora; Maria Gyslane Vasconcelos Sobral; Glauber Gean Vasconcelos; Germana Porto Linhares Almeida; Juliana Rolim Fernandes; Laura Leite da Escóssia Marinho; Daniel Francisco de Mendonça Trompieri; João David De Souza Neto; Juan Alberto Cosquillo Mejia
Journal:  Curr Cardiol Rep       Date:  2019-02-12       Impact factor: 3.955

4.  Modulation of Regulatory T Cells Activity by Distinct CD80 and CD86 Interactions With CD28/CTLA-4 in Chagas Cardiomyopathy.

Authors:  Bruna F Pinto; Nayara I Medeiros; Andrea Teixeira-Carvalho; Jacqueline A Fiuza; Silvana M Eloi-Santos; Maria C P Nunes; Silvana A Silva; Tereza C M Fontes-Cal; Mayara Belchior-Bezerra; Walderez O Dutra; Rodrigo Correa-Oliveira; Juliana A S Gomes
Journal:  Front Cardiovasc Med       Date:  2022-05-19

Review 5.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

6.  Early detection of left ventricular diastolic dysfunction in Chagas' disease.

Authors:  Tomás F Cianciulli; Jorge A Lax; María C Saccheri; Alonso Papantoniou; Luis A Morita; Nilda G Prado; Adriana N Dorelle; Adelina R Riarte; Horacio A Prezioso
Journal:  Cardiovasc Ultrasound       Date:  2006-03-31       Impact factor: 2.062

7.  Antigenicity and diagnostic potential of vaccine candidates in human Chagas disease.

Authors:  Shivali Gupta; Xianxiu Wan; Maria P Zago; Valena C Martinez Sellers; Trevor S Silva; Dadjah Assiah; Monisha Dhiman; Sonia Nuñez; John R Petersen; Juan C Vázquez-Chagoyán; Jose G Estrada-Franco; Nisha Jain Garg
Journal:  PLoS Negl Trop Dis       Date:  2013-01-17

8.  Association of L-ficolin levels and FCN2 genotypes with chronic Chagas disease.

Authors:  Paola R Luz; Angelica B W Boldt; Caroline Grisbach; Jürgen F J Kun; Thirumalaisamy P Velavan; Iara J T Messias-Reason
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

9.  Electrocardiographic abnormalities in elderly Chagas disease patients: 10-year follow-up of the Bambui Cohort Study of Aging.

Authors:  Antonio Luiz P Ribeiro; Milena S Marcolino; Ronald J Prineas; Maria Fernanda Lima-Costa
Journal:  J Am Heart Assoc       Date:  2014-02-07       Impact factor: 5.501

10.  Heart rate recovery in asymptomatic patients with Chagas disease.

Authors:  Maria Clara Noman de Alencar; Manoel Otávio da Costa Rocha; Márcia Maria de Oliveira Lima; Henrique Silveira Costa; Giovane Rodrigo Sousa; Renata de Carvalho Bicalho Carneiro; Guilherme Canabrava Rodrigues Silva; Fernando Vieira Brandão; Lucas Jordan Kreuser; Antonio Luiz Pinho Ribeiro; Maria Carmo Pereira Nunes
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.